MedTrace Logo

Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit

NCT02910921 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2018-08-06

No results posted yet for this study

Summary

This trial is collaboration between Mayo Clinic, Second Opinion Health (Simon Bloch, [email protected] 408-981-3814) and Allergan. Mayo Clinic investigators are conducting the clinical trial, Second Opinion Health is providing the software for use in the trial (Migraine Alert app for data collection, analysis and machine learning algorithms), and Allergan is providing funding.

The investigators hypothesize that the use of a mobile phone app and Fitbit wearable to collect daily headache diary data, exposure/trigger data and physiologic data will predict the occurrence of migraine attacks with high accuracy. The objective of the trial is to assess the ability to use daily exposure/trigger and symptom data, as well as physiologic data (collected by Fitbit) to create individual predictive migraine models to accurately predict migraine attacks in individual patients via a mobile phone app.

Conditions

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • University of Southern California

    collaborator OTHER

  • Allergan

    collaborator INDUSTRY

  • Second Opinion Health

    lead INDUSTRY

Principal Investigators

  • Rashmi Halker Singh, MD · Mayo Clinic

  • Soma Sahai-Srivastava, MD · University of Southern California

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02910921 on ClinicalTrials.gov